Saved in:
| Main Author: | |
|---|---|
| Format: | Artículo científico |
| Language: | en |
| Published: |
Academia Brasileira de Ciências
2002
|
| Subjects: | |
| Online Access: | https://www.redalyc.org/articulo.oa?id=32774111 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- Pharmaceuticals from natural products: current trends Peter R. Seidl Multidisciplinaria (Ciencias Naturales y Exactas) benefit sharing collection outsourcing integration The use of products extracted from plants for medicinal purposes can be traced to the beginnings of civilizationand up until the end of the nineteenth century natural products were the principal source of medicines. Sincethen their relative importance has oscillated according to the strategies of large pharmaceutical companies.Now that these strategies are changing, there are new opportunities for countries like Brazil, in which alarge proportion of the worlds biodiversity is located. There are, however, new circumstances that must betaken into consideration: material must be collected by groups which are formally authorized to do so andunder the conditions of the Convention of Biological Diversity, the discovery process is being successivelyoutsourced to smaller specialized firms and there is a growing integration with producers of cosmetics andphytomedicines. 2002 artículo científico 0001-3765 https://www.redalyc.org/articulo.oa?id=32774111 en http://www.redalyc.org/revista.oa?id=327 Anais da Academia Brasileira de Ciências application/pdf Academia Brasileira de Ciências Anais da Academia Brasileira de Ciências (Brasil) Num.1 Vol.74